CD95 (APO-1/Fas) and Parkinson's disease
- 1 September 1998
- journal article
- letter
- Published by Wiley in Annals of Neurology
- Vol. 44 (3) , 425
- https://doi.org/10.1002/ana.410440330
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Increased serum levels of soluble CD95 (APO‐1/Fas) in relapsing‐remitting multiple sclerosisAnnals of Neurology, 1998
- Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson diseaseProceedings of the National Academy of Sciences, 1997
- The soluble form of Fas molecule is elevated in parkinsonian brain tissuesNeuroscience Letters, 1996
- Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain.The Journal of Experimental Medicine, 1996
- Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's diseaseNeuroscience Letters, 1994